多发性硬化症的肠道菌群:对病原和治疗的影响
Weiwei Zhang1, Ying Wang1, Mingqin Zhu1
1Department of Neurology, the First Hospital of Jilin University, Jilin University, Changchun, Jilin Province, China.
Neural regeneration research
|December 5, 2023
概括
多发性硬化症 (MS) 涉及到中枢神经系统的炎症. 肠道菌群的破坏,或失调,可能会影响多发性硬化症的免疫反应,突出显示肠-大脑轴.
科学领域:
- 神经免疫学 神经免疫学
- 微生物组研究 微生物组研究
- 中枢神经系统疾病 中枢神经系统疾病
背景情况:
- 多发性硬化症 (MS) 是中枢神经系统 (CNS) 的一种慢性炎症性,脱髓性和神经退行性疾病.
- 目前的多发性硬化疗法可以控制症状和缓慢进展,但不能提供治愈.
- 肠-大脑轴描述了肠道微生物群和中枢神经系统之间的双向通信,影响免疫和神经功能.
研究的目的:
- 审查当前对肠道菌群在多发性硬化症病变发生过程中的作用的理解.
- 探索肠-大脑轴调节失调在MS中的影响.
- 为了确定肠道微生物群中的潜在治疗点,用于MS管理.
主要方法:
- 对调查多发性硬化症肠道微生物组的研究进行文献综述.
- 对肠道失调,全身炎症和免疫系统调节的研究进行分析.
- 综合关于肠-大脑轴的发现及其与MS病变发生的相关性.
主要成果:
- 肠道失调与全身炎症和与MS相关的免疫反应改变有关.
- 肠道微生物组的组成可能会影响多发性硬化症的发展和进展.
- 肠-大脑轴是微生物失衡可能影响中枢神经系统健康的重要途径.
结论:
- 肠道菌群在调节多发性硬化症相关的免疫反应方面发挥着至关重要的作用.
- 了解肠-大脑轴对于开发新和有效的MS疗法至关重要.
- 准肠道微生物组为未来多发性硬化症治疗策略提供了一个有希望的途径.
更多相关视频
相关概念视频
Irritable Bowel Syndrome I: Introduction
280
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
280
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
335
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
335
Inflammatory Bowel Disease IV: Pharmacological Management
130
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
130
Bacterial Flora of the Large Intestine
468
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
468
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
168
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
168


